-AP New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations. The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine. If Pfizer is...
More »SEARCH RESULT
Total Matching Records found : 126
Delhi can deal with pollution -Kirit Parikh & Jyoti Parikh
-The Indian Express The Aam Aadmi Party’s strategy is a good one for some immediate relief. However, it must initiate action on all the other measures now. Delhi has become the most air polluted city in the world. Urgent and effective actions are needed to bring the pollution level down. The cost to the health of Delhi citizens far exceeds any cost that some may have to bear to reduce it....
More »Hepatitis C cure may cost as low as Rs 67k -Reema Nagarajan
-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...
More »Centre receives proposal for commercial planting of GM mustard -Nitin Sethi
-Business Standard Since the United Progressive Alliance (UPA) government put a moratorium on commercial cropping of Monsanto's Bt Brinjal in 2010, the Centre has received the first- ever proposal for clearance in five years to let farmers grow a transgenic food crop - a genetically modified hybrid variety of the mustard plant. The decision on the proposal would have to be taken by the environment ministry on behalf of the Union...
More »Pharma companies team up to clean industry’s image
-The Times of India MUMBAI: For the first time ever, some of India's biggest pharmaceutical companies, cutting across their respective associations and representing nearly half the Rs 93,000 crore market, have come together to push for ethical marketing practices to clean up the industry's image. The forum, comprising of 40 to 50 domestic and MNC firms, had its first closed-door meeting on October 14. It has made a "voluntary and moral commitment"...
More »
